Troy Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-33,000
Closed -$1.22M 42
2020
Q4
$1.22M Sell
33,000
-1,782
-5% -$65.4K 0.02% 37
2020
Q3
$1.21M Hold
34,782
0.03% 37
2020
Q2
$1.08M Hold
34,782
0.03% 39
2020
Q1
$1.08M Hold
34,782
0.04% 38
2019
Q4
$1.29M Hold
34,782
0.05% 38
2019
Q3
$1.19M Hold
34,782
0.05% 36
2019
Q2
$1.43M Hold
34,782
0.06% 36
2019
Q1
$1.4M Hold
34,782
0.07% 37
2018
Q4
$1.44M Hold
34,782
0.07% 35
2018
Q3
$1.45M Hold
34,782
0.07% 37
2018
Q2
$1.2M Hold
34,782
0.06% 37
2018
Q1
$1.17M Hold
34,782
0.05% 38
2017
Q4
$1.2M Hold
34,782
0.05% 37
2017
Q3
$1.18M Buy
+34,782
New +$1.12M 0.05% 38
2016
Q4
Sell
-34,782
Closed -$1.12M 59
2016
Q3
$1.12M Hold
34,782
0.06% 27
2016
Q2
$1.16M Hold
34,782
0.06% 26
2016
Q1
$978K Hold
34,782
0.05% 26
2015
Q4
$1.06M Hold
34,782
0.06% 26
2015
Q3
$1.04M Hold
34,782
0.06% 26
2015
Q2
$1.11M Hold
34,782
0.07% 22
2015
Q1
$115K Hold
34,782
1.02% 24
2014
Q4
$1.13M Buy
+34,782
New +$997K 0.07% 22

Other funds holding PFE

Troy Asset Management's PFE Position: Q1 2021 in Review

Troy Asset Management sold out of Pfizer (PFE) in Q1 2021, closing a stake of 33,000 shares — an estimated $1.22M sold.

Troy Asset Management first reported a position in PFE in Q4 2014 and held it in 22 quarters. The position peaked at $1.45M in Q3 2018. 2,675 funds tracked by Wall St. Rank hold PFE as of Q1 2021.

  • Troy Asset Management reported no remaining Pfizer position as of Q1 2021 after selling out during the quarter.
  • Troy Asset Management sold 33,000 Pfizer shares in Q1 2021, an estimated $1.22M.
  • Troy Asset Management first reported a position in Pfizer in Q4 2014 and held it in 22 quarters.
  • Troy Asset Management's Pfizer position peaked at $1.45M in Q3 2018.
  • 2,675 funds tracked by Wall St. Rank held Pfizer as of Q1 2021.

Based on Troy Asset Management's 13F filing for Q1 2021, filed 13 May 2021.